Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from ...

The K8 implant, a first-in-class dual inflammasome inhibitor, demonstrated positive efficacy and safety at 3 months in five ...

Alcohol consumption may trigger worse allergic reactions in patients with nut allergies, according to a study published in ...

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by ...

The prevalence of intraventricular hemorrhage among preterm infants has not changed over time, but it occurs later in life ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The risk for acne relapse following isotretinoin use is reduced with higher cumulative doses, suggesting individualized ...

In 2024, there were numerous trials and a few regulatory moves related to advancements in lipid management for the prevention ...

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...